Literature DB >> 25280150

Cerebrovascular autoregulation in diabetic ketoacidosis: time to go with the (microvascular cerebral blood) flow!

Michael J Whalen1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25280150      PMCID： PMC4899045          DOI： 10.1097/PCC.0000000000000204

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN： 1529-7535            Impact factor:   3.624


× No keyword cloud information.
  16 in total

1.  Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema.

Authors:  James P Marcin; Nicole Glaser; Peter Barnett; Ian McCaslin; David Nelson; Jennifer Trainor; Jeffrey Louie; Francine Kaufman; Kimberly Quayle; Mark Roback; Richard Malley; Nathan Kuppermann
Journal:  J Pediatr       Date:  2002-12       Impact factor: 4.406

2.  Change in mean transit time, apparent diffusion coefficient, and cerebral blood volume during pediatric diabetic ketoacidosis treatment.

Authors:  Monica S Vavilala; Ken I Marro; Todd L Richards; Joan S Roberts; Parichat Curry; Catherine Pihoker; Heidi Bradford; Dennis Shaw
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

3.  Xenon-CT and transcranial Doppler in poor-grade or complicated aneurysmatic subarachnoid hemorrhage patients undergoing aggressive management of intracranial hypertension.

Authors:  Arturo Chieregato; Giuseppe Sabia; Alessandra Tanfani; Christian Compagnone; Fernanda Tagliaferri; Luigi Targa
Journal:  Intensive Care Med       Date:  2006-06-17       Impact factor: 17.440

4.  Subclinical cerebral edema in children with diabetic ketoacidosis randomized to 2 different rehydration protocols.

Authors:  Nicole S Glaser; Sandra L Wootton-Gorges; Michael H Buonocore; Daniel J Tancredi; James P Marcin; Ryan Caltagirone; Yvonne Lee; Christopher Murphy; Nathan Kuppermann
Journal:  Pediatrics       Date:  2012-12-10       Impact factor: 7.124

5.  Cerebral hyperemia and impaired cerebral autoregulation associated with diabetic ketoacidosis in critically ill children.

Authors:  Joan S Roberts; Monica S Vavilala; Kenneth A Schenkman; Dennis Shaw; Lynn D Martin; Arthur M Lam
Journal:  Crit Care Med       Date:  2006-08       Impact factor: 7.598

6.  Noninvasive measurement of cerebral blood flow and blood oxygenation using near-infrared and diffuse correlation spectroscopies in critically brain-injured adults.

Authors:  Meeri N Kim; Turgut Durduran; Suzanne Frangos; Brian L Edlow; Erin M Buckley; Heather E Moss; Chao Zhou; Guoqiang Yu; Regine Choe; Eileen Maloney-Wilensky; Ronald L Wolf; M Sean Grady; Joel H Greenberg; Joshua M Levine; Arjun G Yodh; John A Detre; W Andrew Kofke
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

7.  Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment.

Authors:  Monica S Vavilala; Todd L Richards; Joan S Roberts; Harvey Chiu; Catherine Pihoker; Heidi Bradford; Kristina Deeter; Ken I Marro; Dennis Shaw
Journal:  Pediatr Crit Care Med       Date:  2010-05       Impact factor: 3.624

8.  Mechanism of cerebral edema in children with diabetic ketoacidosis.

Authors:  Nicole S Glaser; Sandra L Wootton-Gorges; James P Marcin; Michael H Buonocore; Joseph Dicarlo; E Kirk Neely; Patrick Barnes; Jenny Bottomly; Nathan Kuppermann
Journal:  J Pediatr       Date:  2004-08       Impact factor: 4.406

9.  Critical thresholds for cerebrovascular reactivity after traumatic brain injury.

Authors:  E Sorrentino; J Diedler; M Kasprowicz; K P Budohoski; C Haubrich; P Smielewski; J G Outtrim; A Manktelow; P J Hutchinson; J D Pickard; D K Menon; M Czosnyka
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

10.  Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage.

Authors:  Pawan S Minhas; David K Menon; Piotr Smielewski; Marek Czosnyka; Peter J Kirkpatrick; John C Clark; John D Pickard
Journal:  Neurosurgery       Date:  2003-05       Impact factor: 4.654
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.